STOCK TITAN

22nd Century Group Inc - XXII STOCK NEWS

Welcome to our dedicated news page for 22nd Century Group (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22nd Century Group.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 22nd Century Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 22nd Century Group's position in the market.

Rhea-AI Summary
22nd Century Group, Inc. announces the resignation of Directors Nora Sullivan and James Mish, aiming to reduce the board size to four seats to enhance corporate cost efficiency. Larry Firestone, Chairman and CEO, expresses gratitude for their service and emphasizes the company's focus on achieving breakeven operations, expecting to save over $1 million annually.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
Rhea-AI Summary
22nd Century Group, Inc. (Nasdaq: XXII) has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company continues to focus on growing sales with new contracts and progressing towards cash positive operations. Chairman and CEO Larry Firestone expressed pleasure in meeting Nasdaq's standards, highlighting the ongoing efforts to enhance the business through steady progress and the pursuit of profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
22nd Century Group, Inc. (XXII) will participate in the Planet MicroCap Showcase on May 1-2, 2024, presenting at 3:30 PM Pacific Time. Investors can access the live presentation via webcast. The company will also host individual investor meetings on May 2, 2024, at the Paris Hotel & Casino in Las Vegas, NV.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.17%
Tags
conferences
Rhea-AI Summary
22nd Century Group, Inc. (XXII) expands its Pinnacle private label brand to include cigarillo products at a top-5 U.S. gas station convenience store chain, experiencing over 10% growth in re-order volumes. The company aims to boost revenue and profitability through new product offerings and increased production volumes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
none
-
Rhea-AI Summary
22nd Century Group, Inc. (XXII) strengthens its financial position with a $4.2 million capital infusion, eliminates senior secured debt through potential debt for equity exchanges, and appoints new senior leadership team members to drive shareholder value. The company aims to become cash positive by Q1 2025 with new contract manufacturing deals and plans for a tobacco harm reduction category.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.12%
Tags
none
-
Rhea-AI Summary
22nd Century Group, Inc. (XXII) has signed a new contract manufacturing agreement for the production of conventional cigarette products, expected to boost CMO volumes by over 20% starting in the second quarter of 2024. The company aims to grow its contract manufacturing business in North Carolina, increase revenue, improve gross margin, and achieve breakeven operations by Q1 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.11%
Tags
none
Rhea-AI Summary
22nd Century Group, Inc. (XXII) reported $7.4 million net revenue in Q4 2023, exited hemp/cannabis operations, reduced operating costs, and focused on tobacco harm reduction. The company aims to increase sales, improve gross margin, and break even by Q1 2025 through VLN® product growth. Despite revenue decline and increased losses, the company is restructuring for future financial strength.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.75%
Tags
-
Rhea-AI Summary
22nd Century Group, Inc. (XXII) will host a live webcast on March 28, 2024, to discuss its 2023 fourth quarter results. The webcast will feature financial review by Larry Firestone, CEO, and Hugh Kinsman, CFO, followed by a Q&A session. Access the webcast on the Company's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.44%
Tags
-
Rhea-AI Summary
22nd Century Group, Inc. (XXII) announces a reduction in board compensation expenses expected to save over $1 million annually in 2024. The company aims to align the board with a lean operating commitment, focusing on efficiency and value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.08%
Tags
none
Rhea-AI Summary
22nd Century Group, Inc. (NASDAQ: XXII) will present at the Emerging Growth Conference on February 8, 2024. Larry Firestone, Chairman and CEO, will participate in an interactive Q&A session. Investors can register for free to attend online or view the archived webcast on EmergingGrowth.com and YouTube.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.43%
Tags
conferences acquisition
22nd Century Group Inc

Nasdaq:XXII

XXII Rankings

XXII Stock Data

9.41M
3.28M
0.65%
6.58%
5.51%
Tobacco Manufacturing
Manufacturing
Link
United States
Mocksville

About XXII

with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.